Many research frameworks start between 100 and 250 mcg daily for the first 3 days
Patients often experience decreased appetite, fewer cravings, increased energy, and marked improvements in vital health metrics, including blood pressure and cholesterol levels
[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability
Some patients find that administering the injection in the evening may be more practical, though this is anecdotal and not specifically recommended in the product information
Park, D., Takahashi, Y., Kang, J., Yim, Y., Kim, J., Lee, J., Lee, K., Lee, J., & Lee, S